132523-92-3
Chemical Structure
CK-3197
- CAS No.: 132523-92-3
- Formula:C23H22N4O3
- Molecular Weight:402.45
IUPAC Name: 1-benzoyl-4-ethyl-5-(4-(2-methyl-4,5-dihydro-1H-imidazol-1-yl)benzoyl)-1,3-dihydro-2H-imidazol-2-one
InChIKey: SQXAAJDJSKQMNK-UHFFFAOYSA-N
SMILES: O=C(C1=C(CC)NC(N1C(C2=CC=CC=C2)=O)=O)C3=CC=C(N4C(C)=NCC4)C=C3
Biological Activity: CK-3197 is a weak inhibitor of Peak lll cyclic 3'5'-adenosine monophosphate phosphodiesterase (CAMP PDEl). CK-3197 has hemodynamic and myocardial energetic effects in vivo. CK-3197 is an imidazolone derivative used as a selective positive inotropic agent for congestive heart failure[1].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
CK-3197 | CK-3197 is a weak inhibitor of Peak lll cyclic 3'5'-adenosine monophosphate phosphodiesterase (CAMP PDEl). CK-3197 has hemodynamic and myocardial energetic effects in vivo. CK-3197 is an imidazolone derivative used as a selective positive inotropic agent for congestive heart failure. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
Keywords
